We are delighted to announce your board members effective from 1st October 2025, who will be working on your behalf to ensure EPHMRA continues to deliver value to its members.

President: Karsten Trautmann, Head GSI Center of Excellence, Merck KGaA

Industry Members (2025 - 2026)

Ana Maria Aguirre-Arteta, Global POP* Governance Senior Director, Novartis 

Hilary Fischer, Executive Director, Global Business Insights & Analytics, Organon

Lauren Halliwell, EU Insights Lead - Global Rare Disease Hub, UCB 

Paul Warner, Head of Business Operations for Rare and Pipeline, CSL Vifor

Xander Raymakers, International Market Research, Eli Lilly Nederland BV

Agency Members (2025 - 2027)

Amr Khalil, Managing Director, Ripple International

Paula Coyle, Research Director, Beyond Blue

Marcel Slavenburg, Senior Director, SKIM

Elizabeth Kehler, MD, Adelphi Research

Stephen Potts, Director, Purdie Pascoe

We would like to take this opportunity to thank Vijay Chand, AstraZeneca and Mike Pepp, Beyond Blue for their time commitment as they now leave the Board at the end of this month.